Furthermore, engineered CD24-targeted CAR-NK cells effectively and specifically killed the CD24-positive ovarian cancer cell lines OVCAR-3 and SKOV3 both in vitro and in vivo [86]. This evidence concerns the gene CD24 and ovarian carcinoma.